Analyst Price Target is $20.00
▲ +154.78% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for LENSAR in the last 3 months. The average price target is $20.00, with a high forecast of $20.00 and a low forecast of $20.00. The average price target represents a 154.78% upside from the last price of $7.85.
Current Consensus is
The current consensus among 1 polled investment analysts is to buy stock in LENSAR.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida.